医药生物科技LOF(165519)资产负债表
|
2024-12-31 |
2024-06-30 |
2023-12-31 |
2023-06-30 |
资产 |
银行存款 |
- |
- |
- |
17,992,911.26 |
结算备付金 |
19,455.51 |
8,972.40 |
16,432.00 |
33,316.10 |
存出保证金 |
25,823.10 |
7,824.86 |
16,726.44 |
26,369.93 |
交易性金融资产 |
219,453,076.93 |
182,713,096.98 |
240,080,662.69 |
276,365,888.67 |
其中:股票投资 |
219,453,076.93 |
182,713,096.98 |
240,080,662.69 |
276,365,888.67 |
债券投资 |
- |
- |
- |
- |
资产支持证券投资 |
- |
- |
- |
- |
衍生金融资产 |
- |
- |
- |
- |
买入返售金融资产 |
- |
- |
- |
- |
应收证券清算款 |
- |
- |
161,402.28 |
- |
应收利息 |
- |
- |
- |
- |
应收股利 |
- |
- |
- |
- |
应收申购款 |
166,031.07 |
189,505.90 |
1,219,558.04 |
339,273.90 |
其他资产 |
- |
- |
8,940.34 |
3,572.66 |
资产总计 |
233,884,666.45 |
195,189,608.46 |
256,423,931.22 |
294,761,332.52 |
负 债 |
短期借款 |
- |
- |
- |
- |
交易性金融负债 |
- |
- |
- |
- |
衍生金融负债 |
- |
- |
- |
- |
卖出回购金融资产款 |
- |
- |
- |
- |
应付证券清算款 |
- |
758,055.71 |
- |
675,373.37 |
应付赎回款 |
212,831.11 |
143,742.64 |
896,641.25 |
241,799.06 |
应付管理人报酬 |
205,173.50 |
166,912.04 |
217,222.36 |
243,311.42 |
应付托管费 |
41,034.71 |
33,382.41 |
43,444.45 |
53,528.53 |
应付销售服务费 |
5,042.75 |
4,701.83 |
7,124.39 |
5,231.45 |
应付交易费用 |
- |
- |
- |
- |
应交税费 |
- |
- |
821.81 |
1,593.12 |
应付利息 |
- |
- |
- |
- |
应付利润 |
- |
- |
- |
- |
其他负债 |
246,620.70 |
160,129.71 |
324,055.90 |
300,276.10 |
负债合计 |
710,702.77 |
1,266,924.34 |
1,489,310.16 |
1,521,113.05 |
所有者权益 |
实收基金 |
143,635,569.97 |
134,854,217.46 |
141,230,738.51 |
161,833,349.41 |
未分配利润 |
89,538,393.71 |
59,068,466.66 |
113,703,882.55 |
131,406,870.06 |
所有者权益合计 |
233,173,963.68 |
193,922,684.12 |
254,934,621.06 |
293,240,219.47 |
负债及所有者权益总计 |
233,884,666.45 |
195,189,608.46 |
256,423,931.22 |
294,761,332.52 |
欢迎访问证券之星!请点此与我们联系 版权所有: Copyright © 1996-年